Zosano Pharma (ZSANQ)

Zosano Pharma Stock Analysis & Ratings

ZSANQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.11 - $3.69
Previous Close$0.29
Average Volume (3M)445.58K
Market CapN/A
Enterprise ValueN/A
P/E Ratio>-0.1
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Zosano Pharma’s price range in the past 12 months?
Zosano Pharma lowest stock price was $0.11 and its highest was $3.69 in the past 12 months.
    What is Zosano Pharma’s market cap?
    Currently, no data Available
    What is Zosano Pharma’s price target?
    Currently, no data Available
    What do analysts say about Zosano Pharma?
    Not enough analysts have published a price target to provide an average price target.
    When is Zosano Pharma’s upcoming earnings report date?
    Zosano Pharma’s upcoming earnings report date is Aug 11, 2022 which is in 36 days.
      How were Zosano Pharma’s earnings last quarter?
      Zosano Pharma released its earnings results on May 13, 2022. The company reported -$7.86 earnings per share for the quarter, missing the consensus estimate of -$1.75 by -$6.11.
        Is Zosano Pharma overvalued?
        According to Wall Street analysts Zosano Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Zosano Pharma pay dividends?
          Zosano Pharma does not currently pay dividends.
          What is Zosano Pharma’s EPS estimate?
          Zosano Pharma’s EPS estimate is -$0.7.
            How many shares outstanding does Zosano Pharma have?
            Zosano Pharma has 4,902,260 shares outstanding.
              What happened to Zosano Pharma’s price movement after its last earnings report?
              Zosano Pharma reported an EPS of -$7.86 in its last earnings report, missing expectations of -$1.75. Following the earnings report the stock price went down -3.158%.
                Which hedge fund is a major shareholder of Zosano Pharma?
                Among the largest hedge funds holding Zosano Pharma’s share is Aisling Capital Management LP. It holds Zosano Pharma’s shares valued at 21M.


                  Zosano Pharma Stock Analysis

                  Smart Score
                  Not Ranked
                  Price Target
                  No data currently available
                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Zosano Pharma

                  Zosano Pharma Corp. is a clinical stage pharmaceutical company, which engages in the provision of systemic administration of therapeutics to patients. It offers Qtrypta, a drug used orally and nasally to effectively and safely treat acute migraine. The company was founded in January 2012 and is headquartered in Fremont, CA.

                  Similar Stocks
                  Price & Change
                  Radius Health
                  Eli Lilly & Co

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis